关于准备妊娠和辅助生殖技术助孕人群新型冠状病毒疫苗接种的专家建议  

COVID-19 vaccination strategy for planning pregnancy and assisted reproductive technology treatment: expert recommendations

作　　者：北京市人类辅助生殖技术质量控制和改进中心专家组 乔杰[2,3] 马彩虹 梁靓[2,3,4] 任昀 Expert Group for Beijing Human Assisted Reproductive Technology Center For Quality Control and Improvement;Qiao Jie

机构地区：[1]不详 [2]北京大学第三医院 [3]国家妇产疾病临床医学研究中心 [4]北京市人类辅助生殖技术质量控制和改进中心专家组办公室

出　　处：《中华生殖与避孕杂志》2021年第4期296-299,共4页Chinese Journal of Reproduction and Contraception

基　　金：国家自然科学基金(72042013);国家重点研发计划(2018YFC1002106)。

摘　　要：新型冠状病毒疫情暴发以来,世界各国加快新型冠病毒疫苗(简称新冠疫苗)的研发。已有多个候选疫苗进入Ⅲ期临床试验或附条件上市及紧急使用。虽然所有年龄段人群均对新型冠状病毒易感,但孕妇仍被排除在新冠疫苗Ⅲ期临床试验之外,因此无法确定新冠疫苗对妊娠期妇女及其子代的安全性,也缺乏孕期及准备妊娠人群新冠疫苗有效性和安全性的数据。本专家建议参考国内外最新研究进展、相关机构推荐和我国相关政策规范,经过北京市人类辅助生殖技术质量控制和改进中心专家组讨论,为我国准备妊娠和接受辅助生殖技术助孕人群新冠疫苗接种提供指导性意见。The pandemic of COVID-19 has accelerated the development and production of the new coronavirus vaccine worldwide.At present,a number of candidate vaccines have been conditional marketing for emergency use and massive vaccination programs are now being undertaken.Although people of all ages are susceptible to novel coronavirus,pregnant women have traditionally been excluded from clinical trials of COVID-19 vaccines,limited data are available on their efficacy and safety during pregnancy and there is lack of data on the effectiveness and safety of COVID-19 vaccines for planning pregnancy couples.This statement reviews and summarizes relevant research and guidelines about COVID-19 vaccination,which has been discussed by the expert group of Beijing Human Assisted Reproductive Technology Center For Quality Control and Improvement,to provide recommendations on COVID-19 vaccination for planning pregnancy couples and those receiving fertility treatment.

关 键 词：生殖技术 辅助 新型冠状病毒 新型冠状病毒疾病 新型冠状病毒疫苗 

分 类 号：R714.8[医药卫生—妇产科学]